Health Economics

Last updated: February 2008

Please note that we have not yet translated this updated text into all the treatobacco.net languages. We are therefore leaving the old section translations on the site, and will replace them with translations of this update, as soon as we can. We hope this will only be a few weeks. Thank you for your patience.

Suggested citation style: Treatobacco.net. Safety section, Key finding on NRT and cardiovascular disease, http://www.treatobacco.net/safety/key_findings.html, Accessed 28.02.08.

Introduction

The purpose of this economics executive summary is to provide information on economic assessments of interventions to assist smoking cessation and the effect of economic interventions on cessation. It will summarize the roles of unit price increases for tobacco products, the cost-effectiveness of mass media education programs, and reimbursement and support for smoking cessation. Evidence from the economic analysis of nicotine replacement therapy (NRT) and other pharmacotherapy will be reported in addition to the economic impact of reducing patient out-of-pocket costs for accessing effective cessation therapies. Also, evidence on the distribution and availability of NRT will be reported to ascertain its respective impacts on increasing utilization of smoking cessation therapies and interventions. Given the types and nature of the reported economic evidence, recommendations for policy and areas for further research are suggested.